Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
31 studies found for:    "glucose-6-phosphate dehydrogenase deficiency"
Show Display Options
Rank Status Study
1 Completed Comparing G6PD Tests Using Capillary Blood Versus Venous Blood
Condition: Glucose-6 Phosphate Dehydrogenase Deficiency
Intervention: Other: G6PD Test
2 Completed Evaluation of Different G6PD Testing Platforms
Condition: Glucose-6-Phosphate Dehydrogenase Deficiency
Intervention:
3 Not yet recruiting Diet Challenge in G6PD Deficient Egyptian Children: A One- Year Prospective Single Center Study With Genotype - Phenotype Correlation
Condition: Glucose-6-Phosphate Dehydrogenase Deficiency
Intervention: Dietary Supplement: non- fava beans
4 Not yet recruiting Effects of Alpha Lipoic Acid Supplementation in G6PD Deficient Individuals After Acute Exercise
Condition: G6PD Deficiency
Interventions: Dietary Supplement: Alpha-lipoic acid;   Other: Placebo
5 Not yet recruiting Effects of N-acetyl Cystein (NAC) Supplementation in G6PD Deficient Individuals After Acute Exercise
Condition: G6PD Deficiency
Interventions: Drug: N-acetyl cystein;   Other: Placebo
6 Completed Pharmacokinetic and in Vitro Transmission Blocking Activities Study of Primaquine Compare to Methylene Blue in Healthy Volunteer Both G6PD Normal and G6PD Deficiency
Conditions: G6PD Normal;   G6PD Deficient;   Healthy
Intervention: Drug: Regimens (Primaquine, Methylene blue)
7 Completed A Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency
Conditions: Glucosephosphate Dehydrogenase Deficiency;   Favism
Intervention: Drug: Primaquine
8 Recruiting Efficacy of Yinzhihuang Oral Liquid on Indirect Bilirubin of Neonates With Glucose-6-phosphate Dehydrogenase Deficiency
Condition: Neonatal Hyperbilirubinemia
Intervention: Drug: Yinzhihuang Oral Liquid
9 Completed Phase IV Study to Gather More Information About the Safety of ACZONE Gel, 5% in Treating Subjects With Acne Who Have G6PD Deficiency
Condition: Acne Vulgaris
Interventions: Drug: ACZONE Gel, 5%;   Drug: Vehicle
10 Completed G6PD (Glucose-6-phosphate Dehydrogenase) Study to Evaluate Hemolysis Potential of TFQ (Tafenoquine)
Condition: Malaria
Interventions: Drug: Chloroquine;   Drug: Primaquine;   Drug: Tafenoquine
11 Not yet recruiting G6PD Assessment Before Primaquine for Radical Treatment of Vivax Malaria
Condition: Vivax Malaria
Interventions: Drug: Chloroquine;   Drug: Primaquine 0.25 mg/kg/day;   Drug: Primaquine 0.75 mg/kg weekly
12 Completed Safety and Tolerability of Low Dose Primaquine
Conditions: Malaria, Falciparum;   G6PD Deficiency
Interventions: Drug: Dihydroartemisinin piperaquine (DHA PP);   Drug: Primaquine
13 Completed Erythrocyte and Adipocyte G6PD Activity Levels in Obesity
Conditions: Diabetes;   Obesity
Intervention:
14 Not yet recruiting Validation of New G6PD Point of Care Tests Against Gold Standard Quantitative
Conditions: Validation;   Biosensors;   Genotyping
Intervention:
15 Completed Determining a Tolerable Dose of Primaquine in G6PD-deficient Persons Without Malaria in Mali
Condition: Malaria
Intervention: Drug: Primaquine
16 Terminated Evaluation of the Safety of Primaquine in Combination With Dihydroartemisinin-piperaquine in G6PD Deficient Males in The Gambia
Condition: Malaria
Interventions: Drug: Dihydroartemisinin-piperaquine (DHAP) administered to G6PD deficient;   Drug: Dihydroartemisinin-piperaquine (DHAP) + 0.25 mg/kg primaquine administered to G6PD deficient;   Drug: Dihydroartemisinin-piperaquine (DHAP) + 0.4 mg/kg primaquine administered to G6PD deficient;   Drug: Dihydroartemisinin-piperaquine (DHAP) + 0.25 mg/kg primaquine administered to G6PD normal;   Drug: Dihydroartemisinin-piperaquine (DHAP) + 0.4 mg/kg primaquine administered to G6PD normal
17 Completed Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia
Conditions: Glucosephosphate Dehydrogenase Deficiency;   Hyperbilirubinemia;   Hemolytic Disease of Newborn
Intervention: Drug: tin mesoporphyrin
18 Completed Safety of Primaquine + Artemether-lumefantrine in G6PD Deficient Males With an Asymptomatic Malaria Infection (SAFEPRIM)
Condition: Malaria
Interventions: Drug: Artemether-Lumefantrine (AL) + 0.25 mg/kg primaquine;   Drug: Artemether-Lumefantrine (AL) combination;   Drug: Artemether-Lumefantrine (AL) + 0.4 mg/kg primaquine
19 Completed A Study to Assess Safety of Current Standard Malaria Treatment and an Assessment of G6PD Status in South-east Bangladesh
Condition: Malaria
Interventions: Drug: chloroquine;   Drug: Artemether-lumefantrine combination;   Drug: Primaquine
20 Completed Examination of Protective Factors Against Severe Malaria
Conditions: Malaria;   Severe Malaria
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.